86
Views
0
CrossRef citations to date
0
Altmetric
Research Report

Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & show all
Pages 806-808 | Received 25 Jul 2022, Accepted 25 Sep 2022, Published online: 25 Jan 2023

References

  • Munier FL, Beck-Popovic M, Chantada GL, et al. Corrigendum to “conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”” [Prog. Retina Eye Res. 73 (2019) 100764] [published online ahead of print, 2020 Apr 8]. Prog Retin Eye Res. 2020:100857. doi:10.1016/j.preteyeres.2020.100857.
  • Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011 June;129(6):732–37. doi:10.1001/archophthalmol.2011.5.
  • Abramson DH. Retinoblastoma: saving life with vision. Annu Rev Med. 2014;65:171–84. doi:10.1146/annurev-med-061312-123455.
  • Chantada GL, Dunkel IJ, Schaiquevich PS, Grynszpancholc EL, Francis J, Ceciliano A, Zubizarreta PA, Fandiño AC, Abramson DH. Twenty-year collaboration between North American and South American retinoblastoma programs. J Glob Oncol. 2016 Dec;2(6):347–52. doi:10.1200/JGO.2015.002782.
  • Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. http://www.survivorshipguidelines.org/pdf/2018/COG_LTFU_Guidelines_v5.pdf.
  • Kellie SJ, Kingston JE. Ovarian failure after high-dose melphalan in adolescents. Lancet. 1987;1(8547):1425. doi:10.1016/s0140-6736(87)90606-4.
  • Bresters D, Emons JA, Nuri N, Ball LM, Kollen WJW, Hannema SE, Bakker-Steeneveld JDJ, van der Bom JG, Oostdijk W. Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood. Pediatr Blood Cancer. 2014 Nov;61(11):2048–53. doi:10.1002/pbc.25162.
  • Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291–303. doi:10.1136/adc.44.235.291.
  • Langeveld NE, Grootenhuis MA, Voûte PA, de Haan RJ, van den Bos C. Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology. 2004 Dec;13(12):867–81. doi:10.1002/pon.800.
  • Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, Wallace WH, Wang ET, Loren AW. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018 Jan 7;36(19):1994–2001. doi:10.1200/JCO.2018.78.1914.
  • Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006 June 20;24(18):2917–31. doi:10.1200/JCO.2006.06.5888.
  • Even-Or E, Ben-Haroush A, Yahel A, Yaniv I, Stein J. Fertility after treatment with high dose melphalan in women with acute myelogenous leukemia. Pediatr Blood Cancer. 2016;63(2):334–36. doi:10.1002/pbc.25765.
  • Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Stovall M, Meacham LR, Green DM, Weathers R, Ginsberg JP, et al. Endocrine abnormalities in aging survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2016;34(27):3240–47. doi:10.1200/JCO.2016.66.6545.
  • Green DM, Nolan VG, Goodman PJ, Whitton JA, Srivastava D, Leisenring WM, Neglia JP, Sklar CA, Kaste SC, Hudson MM, et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2014;61(1):53–67. doi:10.1002/pbc.24679.
  • Schaiquevich P, Buitrago E, Taich P, Torbidoni A, Ceciliano A, Fandino A, Asprea M, Requejo F, Abramson DH, Bramuglia GF, et al. Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients. Invest Ophthalmol Vis Sci. 2012 June 28;53(7):4205–12. doi:10.1167/iovs.12-9501.
  • Dunkel IJ, Shi W, Salvaggio K, Marr BP, Brodie SE, Gobin YP, Abramson DH. Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastoma. PLoS One. 2014 [Published 2014 Oct 10];9(10):e108692. doi:10.1371/journal.pone.0108692.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.